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Abstract
Background: The N-acetyltransferase 2 (NAT2) gene plays a crucial role in the metabolism of
many drugs and xenobiotics. As it represents a likely target of population-specific selection
pressures, we fully sequenced the NAT2 coding region in 97 Mandenka individuals from Senegal,
and compared these sequences to extant data on other African populations. The Mandenka data
were further included in a worldwide dataset composed of 41 published population samples (6,727
individuals) from four continental regions that were adequately genotyped for all common NAT2
variants so as to provide further insights into the worldwide haplotype diversity and population
structure at NAT2.
Results: The sequencing analysis of the NAT2 gene in the Mandenka sample revealed twelve
polymorphic sites in the coding exon (two of which are newly identified mutations, C345T and
C638T), defining 16 haplotypes. High diversity and no molecular signal of departure from neutrality
were observed in this West African sample. On the basis of the worldwide genotyping survey
dataset, we found a strong genetic structure differentiating East Asians from both Europeans and
sub-Saharan Africans. This pattern could result from region- or population-specific selective
pressures acting at this locus, as further suggested in the HapMap data by extremely high values of
FST for a few SNPs positions in the NAT2 coding exon (T341C, C481T and A803G) in comparison
to the empirical distribution of FST values accross the whole 400-kb region of the NAT gene family.
Conclusion: Patterns of sequence variation at NAT2 are consistent with selective neutrality in all
sub-Saharan African populations investigated, whereas the high level of population differentiation
between Europeans and East Asians inferred from SNPs could suggest population-specific selective
pressures acting at this locus, probably caused by differences in diet or exposure to other
environmental signals.
Background
The N-acetyltransferase 2 (NAT2) gene plays a crucial role
in the metabolism of xenobiotics, including many clini-
cally useful drugs and exogenous chemicals present in the
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diet, cigarette smoke and the environment [1]. Extensive
polymorphism in NAT2 gives rise to a wide interindivid-
ual variation in N-acetylation capacity. In particular, a
clear bimodal distribution is observed that segregates the
rapid acetylator phenotype, associated with a normal
acetylation capacity, from the slow acetylator one, charac-
terized by a reduced enzyme activity. These two main met-
abolic phenotypes occur with varying prevalence in
populations of different ethnic origin [2].
The clinical consequences of the acetylation polymor-
phism can be severe if standard drug doses are applied,
exposing patients to an increased risk of adverse drug reac-
tions or a lack of therapeutic efficacy [3]. In addition, in
the last decades, an increasing number of epidemiological
studies have attempted to relate acetylation phenotype to
a variety of complex human disorders, such as bladder
cancer, atopic diseases, diabetes, Parkinson's disease and
many others (see Butcher et al. [4] for a review). However,
up to now, association studies in NAT2 have led to con-
flicting results among (and even within) human popula-
tions and most association findings have been difficult to
replicate. One reason for these inconsistencies may relate
to the fact that almost all studies focused on a limited
number of candidate polymorphisms, which were not
necessarily the same from one study to another [5,6]. A
shift toward a gene-based approach in which all common
variation within a gene is considered jointly is advocated
for future association studies [7]. By capturing all of the
potential risk-conferring variations within NAT2, this
approach should resolve much of the controversial issues
of candidate-polymorphism studies.
There is now a large body of information on the distribu-
tion of NAT2 genetic variants all over the world [8]. How-
ever, most published reports used simplified protocols for
NAT2 allele detection, omitting analysis of several poly-
morphic positions (such as G191A, C282T, T341C, and
A803G within the coding region). They focused on a lim-
ited number of "indicator" mutations, thought to be
tightly linked with other mutations and predictive of
acetylator status, and have based allele designation on
this. Such incomplete genotyping methods wrongly type
different alleles as the same and may lead to misclassifica-
tion of genotypes and deduced phenotypes [9]. Therefore,
results of such investigations may be substantially biased
and fail to provide an accurate picture of NAT2 allele dis-
tribution in worldwide populations.
In an attempt to better characterize the worldwide haplo-
type diversity and LD structure of NAT2, we performed an
extensive survey of the literature to identify those samples
that were adequately genotyped for all common variants
in  NAT2. In total, 41 population samples (including
6,727 individuals) from four continental regions (Africa,
Europe, Asia, America) were selected and jointly analyzed.
In addition, we performed full sequencing analysis of the
NAT2 coding region in a large and ethnically well defined
Mandenka sample from Eastern Senegal so as to further
characterize African diversity at this locus and to detect
novel variants not yet reported. Beyond a simple descrip-
tion of NAT2 gene diversity, the goal of the present study
was to provide further insights into the evolutionary
forces that most likely shaped NAT2 genetic variation in
humans. In particular, three levels of diversity (intrapop-
ulation, interpopulation, and interspecies variability)
were used to investigate to what extent present NAT2 var-
iation patterns solely reflect stochastic events of human
evolution, or are distorted by natural selection.
Results
NAT2 sequence diversity in the Mandenka and variation 
in Sub-Saharan Africa
Results of the sequencing analysis of NAT2 in the Man-
denka sample are reported in Table 1. A total of 12 poly-
morphic sites were identified, all located within the NAT2
coding exon. Two of them were singletons confirmed by
resequencing. Apart from the seven SNPs that are com-
monly found in human populations, we found three
additional variants that have been recently reported by
Patin et al. [10] in several sub-Saharan African samples
(C403G, G609T, G838A), and two novel nucleotide
changes not yet described: C345T and C638T, which
occurred at a frequency of 0.026 and 0.01, respectively.
C638T leads to an amino acid change (P213L). Sixteen
distinct haplotypes were inferred by the PHASE program,
including two which were recently described in the Patin
et al. data set [10] and four that are newly described here.
Among these six haplotypes, four contain inactivating
mutations and are thus predicted as 'slow alleles', whereas
the other two (NAT2*12g and NAT2*12H) contain a non-
synonymous mutation (G609T or C403G) whose impact
on phenotype is unknown. From diplotype configura-
tions at NAT2  in the Mandenka, we inferred 48.5%,
39.2%, and 7.2% of slow, intermediate, and rapid acetyla-
tors, respectively. The remaining 5.1% individuals had an
unknown acetylator status as they were carriers of either a
NAT2*12g or a NAT2*12H haplotype.
Summary statistics of genetic variation at the NAT2 cod-
ing region (870 bp) in the Mandenka and the 12 African
samples of Patin et al. [10] are reported in Table 2. Results
for the entire surveyed region (1188 bp) in the Mandenka
are also indicated. Patterns of diversity in this sample are
entirely consistent with those displayed by the 12 other
African samples. The mean values of the two nucleotide-
variability measures, π  and θw, for the 13 samples are
0.268% and 0.221%, respectively. None of the tests of
selective neutrality, performed on each sample both at the
intrapopulation and at the interspecies levels, yielded sig-BMC Genetics 2008, 9:21 http://www.biomedcentral.com/1471-2156/9/21
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nificant results (not shown). This suggests that patterns of
diversity at NAT2 are consistent with the hypothesis of
selective neutrality and constant population size. The
average sequence divergence between human and chim-
panzee for NAT2 coding exon was of 1.6%, and the aver-
age substitution rate of 1.6 × 10-9 per nucleotide and year.
All samples provided similar estimates both for Ne, the
current effective population size, and TMRCA, the coales-
cence time back to the most recent common ancestor:
average values were 14,218 individuals and 1.077 My,
Table 1: SNP and haplotype frequencies in the Mandenka sample.
Nucleotide 
Changea
G191A C282T T341C C345Td C403Gc C481T G590A G609Tc C638Td A803G G838Ac G857A
Amino Acid 
Change
R64Q None I114T None L135V None R197Q E203D P213L K268R V280M G286E
SNP 
Frequency
0.1031 0.3041 0.3608 0.0258 0.0206 0.3454 0.1701 0.0051 0.0103 0.5052 0.0051 0.0722
Haplotypeb Haplotype 
Frequency
NAT2*4e G C T C C C G G C A G G 0.0928
NAT2*5A .. C ..T ...... 0 . 0 1 0 3
NAT2*5B .. C ..T ... G .. 0 . 3 3 0 0
NAT2*5C .. C ...... G .. 0 . 0 1 5 5
NAT2*6A . T .... A ..... 0 . 1 2 8 9
NAT2*7B . T ......... A 0 . 0 6 7 0
NAT2*12A .... .... .G.. 0 . 1 2 8 9
NAT2*13 . T .......... 0 . 0 5 1 5
NAT2*14A A ........... 0 . 0 8 7 6
N A T 2 * 1 4 B A T .......... 0 . 0 1 5 5
NAT2*12gc .... ...T.G.. 0 . 0 0 5 2
NAT2*6Jd . T .... A .... A 0 . 0 0 5 2
NAT2*12Hc ....G... .G.. 0 . 0 2 0 6
NAT2*5Md . . C . . T . . . G A . 0.0052
NAT2*6Kd . T .... A .T... 0 . 0 1 0 3
NAT2*6Ld . T .T.. A ..... 0 . 0 2 5 8
2Nf 194
a Polymorphic sites were numbered considering +1 as the A of the translation start codon in the cDNA sequence (GenBank CR407631)
b NAT2 haplotypes were named in accordance with the consensus gene nomenclature of human NAT2 alleles [65]
c These SNPs/haplotypes have been recently described in Patin et al. [10]
d Newly reported SNPs/haplotypes in the present study
e NAT2*4 is the reference allele that was shown to be the ancestral haplotype through outgroup comparisons with the chimpanzee and rhesus 
monkey sequences
f Total number of chromosomes in the Mandenka sample
Table 2: Summary statistics and coalescence estimates for NAT2 sequence data.
Sample Ha πb θw
c Ned TMRCA
e
Mandenka (1188 bp) 0.837 0.218 0.173 10,932 799 ± 267
Mandenka (870 bp) 0.837 0.298 0.238 15,658 1,145 ± 382
12 African populationsf (870 bp)
meang 0.806 0.265 0.220 14,098 1,071 ± 372
standard deviationg ± 0.061 ± 0.038 ± 0.034 ± 2,733
minimumg 0.678 0.181 0.156 9,173 947 ± 332
maximumg 0.879 0.302 0.271 19,903 1,297 ± 418
a Haplotype diversity
b Nucleotide diversity per bp (× 10-2) with Jukes and Cantor's correction
c Watterson's estimator of the population mutation parameter per bp (× 10-2)
d Effective population size
e Time to the most recent common ancestor (TMRCA) of all sampled genes (in thousand years)
f Sequence data from Patin et al. [10]
g Are reported here the mean (and standard deviation), minimum, and maximum values of the statistics computed for each of the twelve sub-
Saharan African samples of Patin et al. [10]BMC Genetics 2008, 9:21 http://www.biomedcentral.com/1471-2156/9/21
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respectively, for the NAT2 coding exon. The age of muta-
tions in the gene genealogy ranged from 96,200 (G857A)
to 496,300 (A803G) years for the seven SNPs that com-
monly occur in human populations. The other polymor-
phisms, only reported to date in sub-Saharan Africans,
had all estimated ages < 50,000 years.
NAT2 worldwide genotyping survey
A total of 6,727 individuals from 41 worldwide samples
were analyzed for their genotype at the seven common
SNPs of the NAT2 gene. All SNPs and populations were in
Hardy-Weinberg equilibrium after Bonferroni correction
for multiple testing. The seven SNPs defined 21 distinct
haplotypes, whose composition in terms of SNP variants
is given in Table 3.
Continental distribution of NAT2 SNP variants and haplotypes
Allele frequency variation of the seven common SNPs of
NAT2 in the 41 sampled populations is shown in Figure
1, and the worldwide distribution of common NAT2 hap-
lotypes is displayed in Figure 2A. Figure 1 clearly high-
lights the high correlation in frequency of the three
variants 341C, 481T, and 803G in Europe, Asia and Amer-
ica. This reflects the high level of LD between these three
SNPs which, in combination, form the NAT2*5B haplo-
type. This variant occurs at a high frequency in Europe but
is rare in populations of Asian origin. In sub-Saharan
Africa, a poorer correlation between 803G and the two
other variants is observed. This can be explained by the
higher frequency of NAT2*12A in Africa, in which the
803G variant occurs in isolation. The 191A variant (which
defines the NAT2*14 cluster) is exclusively present in sub-
Saharan Africa, and the 857A variant (which defines the
NAT2*7  cluster) is mainly found in Asia and Central
America. By contrast, the 590A variant occurs at roughly
similar frequencies (~15–40%) in all worldwide samples,
except in Amerindians where it is rare (0% and 3.7% in
Ngawbe and Embera, respectively). The frequency of the
282T variant only slightly varies among human popula-
tions.
It is clearly apparent from Figures 2A and 2B that sub-
Saharan African populations display greater haplotype
diversity than either Europeans or Asians, and more com-
plex relationships between NAT2  haplotypes are
observed. A larger number of haplotypes of similar fre-
quencies indeed occurs in these populations, generating a
huge number of distinct genotypes. By contrast, in popu-
lations of Asian origin, only a few major haplotypes are
found, namely NAT2*4,  NAT2*6A  and  NAT2*7B. The
mean haplotype diversity was estimated to be 0.80 ± 0.05
in Africans and 0.56 ± 0.09 in East Asians. Europeans dis-
played an intermediate value of 0.70 ± 0.04 [see Addi-
tional file 1].
In East Asia, the ancestral NAT2*4 haplotype associated
with the rapid acetylator-phenotype accounts for more
than 50% of the global variation (Thai excepted), while in
Africa and Europe, the derived haplotypes associated with
the slow-acetylator phenotype are predominant over
NAT2*4. This observation explains the lower proportion
of slow acetylators in East Asians compared to other
human populations [see Additional file 2]. Derived hap-
lotypes associated with the rapid acetylation phenotype
(NAT2*12A,  NAT2*13), are essentially found in Africa
and are particularly frequent in Baka and Bakola Pygmies,
which display a similar proportion of rapid acetylators as
East Asians (83% and 90%, respectively).
Population structure
Several differentiated clusters of populations clearly
appeared in the graphical representation of the MDS (Fig-
ure 3). The sub-Saharan African populations were found
relatively dispersed while Europeans and East Asians
(Thai excepted) formed tight clusters with small genetic
distances between pairs of populations. The proportion of
nonsignificant pairwise FST's at the 5% level within each
continental area was 35% and 44% in Europe and East
Asia, respectively, while it was only of 11% in sub-Saharan
Africa. Among Africans, Somali were genetically the most
similar to Europeans. Bakola Pygmies were found highly
differentiated from all other populations (except from
Baka Pygmies) which could easily be explained by strong
genetic drift due to isolation and small effective size.
Embera and Ngawbe Amerindians did not differentiate
statistically from each other; while in close proximity to
East Asians, they displayed significant FST values with all
other samples. In contrast, Nicaraguans were found very
close to Europeans, in agreement with the Amerindian-
European mixed origin of the sampled individuals. Turk-
men and Kyrgyz displayed NAT2 allele frequencies inter-
mediary to those observed in Europeans and East Asians,
which points to the continuous nature of human genetic
variation worldwide [11]. The MDS plot suggests that
NAT2 genetic differentiation patterns are related to geog-
raphy, which is confirmed by a high and significant corre-
lation coefficient (r = 0.47, P < 10-5) observed between
genetic and geographic distances.
FST gives a measure of the proportion of the genetic vari-
ance explained by differences among populations. The
global FST value estimated for the 41 worldwide samples
was of 0.123 (P < 10-5). When grouping these 41 popula-
tions into five major geographic areas (sub-Saharan
Africa, Europe/North Africa, Central/South Asia, East Asia,
Central America), the vast majority of genetic variation
was shown to occur within populations (83.5%), a high
proportion (15%, P < 10-5) among geographic groups,
and a mere 1.5% (P < 10-5) among populations within
groups. When only three geographic groups were consid-B
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) Table 3: NAT2 haplotypea frequencies in samples of the worldwide genotyping surveyb.
NAT2 Haplotypee
*4 *5A *5B *5C *5D *5E *5M *6A *6B *6C *7A *7B *11A *12A *12B *12C *13 *13B *14A *14B *6Jf Global (2Ng)
SNP positionc (ancestral stated)
1 9 1  ( G ) .................. AA.
282 (C) . . . . . . T T . T . T . . T . T T . T T
341 (T) . CCCCCC ..............
4 8 1  ( C ) .T T.........T..T . T...
590 (G) . . . . . A . AAA .......... A
803 (A) . . G G . . . . . G . . . G G G . . . . .
8 5 7  ( G ) .......... AA ........ A
Population codeh
1 27 1 47 17 0 0 0 34 4 0 0 0 0 34 7 1 13 0 6 11 0 202
2 1 0 1 3 7 3001 1 6 00020920603 1 0 0 100
3 8040000 1 1 00000 3 9 10 1 3 0040 80
4 40 1 3 5000800000 1 9 3060020 60
6 18 2 65 3 0 0 0 32 0 0 0 13 0 30 0 0 10 0 17 3 1 194
7 1 3 0 2 2 8000 3 2 5021071040230 100
8 30 1 9 0000 1 7 0001070000100 48
9 1 3 0 4 5 0000 2 2 0003040010000 88
1 0 1 3 3 1 2 4 2 0000 1 2 7 2003060000200 516
1 1 2 0 1 5 2 1000 2 4 0000000000000 98
1 2 2 2 6 5 4 2000 3 0 0001000050000 120
1 4 4 4 8 1 0 4 6000 5 4 1005010010000 224
1 5 1 8 7 2 0 3 1 8 1 7 000 2 0 6 000 1 5 030070010 774
1 7 1 1 6 5 0 3000 2 8 0002000000000 100
1 8 2 3 3 4 2 0000 1 5 000 1 3 000000000 96
1 9 3 8 3 7 0 6 4 7 6 8 000 4 7 0 000 2 2 0000 2 6 0020 1688
2 1 1 0 9 2 6 1 6 4 3 0 000 1 4 9 000 1 7 010000000 496
2 3 90 4 1 0000 2 9 0001000000000 80
2 5 1 3 4 1 2 2 1 3 1 7 000 1 8 4 000 1 7 030000000 580
2 6 1 4 0 8 2 1 6 2 9 000 1 8 5 000 2 7 010000000 606
2 7 1 3 1 2 9 4000 4 3 0106030000000 100
2 8 3 1 0 2 3 3000 3 0 000 1 2 010000000 100
3 0 1 3 2 040100 4 6 000 3 8 000030000 224
3 2 4 6 060000 2 2 000 1 3 000010000 88
3 3 2 0 8 010010 5 5 000 2 2 000010000 288
3 6 3 5 3 150100 1 2 6 306 7 0 040160000 576
3 8 2 6 0 1 0 0000 3 4 000 1 7 000010000 88
4 1 1 1 4 7 8 6 5000 4 6 1100080230100 274
Global 2234 174 2559 221 2 1 1 2075 16 2 8 321 0 180 14 4 107 0 32 36 1 7988
a NAT2 haplotypes were named in accordance with the consensus gene nomenclature of human NAT2 alleles [65]
b Only the 28 samples with no missing data (i.e., with genotype data available for the seven common SNPs in NAT2) were considered here
c Polymorphic sites were numbered considering +1 as the A of the translation start codon in the cDNA sequence (GenBank CR407631)
d The ancestral state of each SNP was deduced from both the chimpanzee and rhesus monkey sequences, and is represented here as a dot
e Nucleotide substitutions shown in bold have a functional consequence on enzyme activity. Bold-faced haplotypes are 'slow alleles' associated with as decreased acetylation capacity; the others display an enzymatic activity 
comparable to the reference 'rapid' allele NAT2*4
f NAT2*6J is a newly described allele found in the Mandenka sample in the present study (see Table 1). It was predicted to be a 'slow allele' since it contains two inactivating mutations
g Total number of chromosomes
h Samples are numbered according to their population code [see Additional file 1]: (1) 101 Tswana, (2) 50 Ateke Bantus, (3) 40 Bakola Pygmies, (4) 30 Baka Pygmies, (6) 97 Mandenka, (7) 50 Dogons, (8) 24 Somali, (9) 44 
Moroccans, (10) 258 Spanish, (11) 49 Sardinians, (12) 60 French, (14) 112 UK Caucasians, (15) 387 US Caucasians, (17) 50 Swedes, (18) 48 Saami, (19) 844 Germans, (21) 248 Polish, (23) 40 Ashkenazi Jews, (25) 290 Russians, 
(26) 303 Turks, (27) 50 Gujarati, (28) 50 Turkmen, (30) 112 Han Chinese, (32) 44 Chinese, (33) 144 Japanese, (36) 288 Koreans, (38) 44 Thai, (41) 137 Nicaraguans.BMC Genetics 2008, 9:21 http://www.biomedcentral.com/1471-2156/9/21
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ered (35 samples grouped into sub-Saharan Africa,
Europe/North Africa, and East Asia), the among groups
component increased to 19%. The highest continental FST
value was found in sub-Saharan Africa (2.6%, P  =
0.0001), whereas greater homogeneity was observed
within East Asia (1.2%, P < 10-5), and even more so within
Europe/North Africa (0.4%, P = 0.0002). In agreement
with the MDS analysis, differentiation was very low
between Europe (including Moroccans) and sub-Saharan
Africa (FST = 2.6%, P < 10-5), in contrast to the high FST val-
ues observed between Asia and both Europe and Africa
(22.2%, P < 10-5, and 23.2%, P < 10-5, respectively). Like-
wise, differences in the level of population differentiation
were observed among the individual SNPs (Table 4). In
particular, the C282T and G590A polymorphisms (defin-
ing the NAT2*6A haplotype) displayed strikingly low FST
values. By contrast, high FST values were observed for the
three SNPs T341C, C481T, and A803G which define the
NAT2*5B haplotype. The highest FST values at these three
SNPs were observed between European and East Asian
populations (around 40%).
LD analysis
We first tested whether the amount of LD (measured as
the  r2 coefficient between SNP pairs) differed between
human populations. All population samples displayed
similar levels of LD within each geographic area, except
Somali who showed higher LD at NAT2 (average r2 value
= 0.589) than other sub-Saharan African samples and
were, in that respect, more similar to Europeans. The
mean pairwise r2 value between the seven SNPs in the
European samples (0.567 ± 0.075, including Moroccans)
was significantly higher (Wilcoxon's test, P = 0.0002) than
in both East Asians (0.276 ± 0.023) and Africans (0.243 ±
0.050, without Somali). No statistical differences in the
level of LD were found between East Asian and African
populations. However, the proportion of SNP pairs with
r2 ≥ 0.5 was far smaller in sub-Saharan Africans (6.7%)
than in both Europeans (40%) and East Asians (33.3%).
Ashkenazi Jews exhibited the highest level of LD (average
r2 value = 0.763); such an excess of LD is often observed in
founder populations that recently grew from relatively
small sizes [12]. We then tested whether the structure of
LD was similar among populations by computing the cor-
relation between r2 matrices of LD. Mantel's tests gave
highly significant correlation values both between popu-
lation pairs within geographic areas and for pairs of con-
tinental regions (P < 0.0001 with 10,000 permutations).
Thus, although Europeans exhibited higher levels of LD at
NAT2, the pattern of LD in this gene was found to be sim-
ilar across human populations.
Discussion
This study provides a thorough description of NAT2
worldwide genetic diversity. By considering only the sam-
ples adequately characterized for the seven common SNPs
of the NAT2 gene, we avoided biases arising from incom-
plete genotyping studies that may lead to both allele and
phenotype misclassifications. These seven SNPs are the
main polymorphisms occurring in human populations at
NAT2 and their joint analysis has been shown to be highly
predictive of the acetylation phenotype with a prediction
SNP frequencies in the 41 samples of the worldwide genotyping survey Figure 1
SNP frequencies in the 41 samples of the worldwide genotyping survey. Samples are ordered geographically (as in 
Additional file 1), thus including: SSAFR, sub-Saharan Africa (Tswana, Ateke Bantus, Bakola Pygmies, Baka Pygmies, Yoruba, 
Mandenka, Dogons, and Somali); NA, North Africa (Moroccans); EUR, Europe (Spanish, Sardinians, French, French-Canadians, 
UK Caucasians, both US Caucasian samples, Swedes, Saami, both German samples, Polish, Slovaks, Ashkenazi Jews, Romanians, 
Russians, and Turks); CSASIA, Central/South Asia (Gujarati, Turkmen, and Kyrgyz); EASIA, East Asia (the three Chinese, three 
Japanese, and two Korean samples, and Thai); AME, America (Embera, Ngawbe, and Nicaraguans).
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rate close to 100% [13-17]. Such a high concordance
between genotype and phenotype suggests that unknown
NAT2 variants should be present at low frequencies and
therefore may not substantially influence the phenotype
prediction in population studies. Although these state-
ments are tenable in populations that have been exten-
sively studied at NAT2, such as Europeans or East Asians,
it is not yet known if they hold in populations poorly or
inadequately studied for NAT2  gene variation, such as
sub-Saharan African populations. As shown by Patin et al.
[10] and in this study, these populations usually display a
greater allelic diversity and may contain novel variants not
previously reported in populations of European or Asian
origin. Although two new mutations were observed in our
sequencing analysis of NAT2 in the Mandenka sample
(C345T and C638T, see Table 1), we did not disclose yet
any new major polymorphism apart from the seven
acknowledged ones. Consequently, only a small propor-
tion of subjects (5%) would have been classified differ-
ently regarding their acetylator status if they had been
tested for only the seven common SNPs of NAT2 (these
5% individuals with an unknown acetylator status would
have been classified as either intermediate or rapid
acetylators). A similar observation has been made for sev-
(A) Haplotype frequencies in the 28 samples genotyped for all seven common SNPs at NAT2 (i.e., without missing data), taken  from the worldwide genotyping survey Figure 2
(A) Haplotype frequencies in the 28 samples genotyped for all seven common SNPs at NAT2 (i.e., without 
missing data), taken from the worldwide genotyping survey. Single populations are reported on the left side of the 
plot, with population codes in brackets; geographic areas are indicated on the right side, as follows: SSAFR, sub-Saharan Africa; 
NA, North Africa; EUR, Europe; CSASIA, Central/South Asia; EASIA, East Asia; AME, America. Only haplotypes with frequen-
cies > 5% in at least one geographical region were represented individually; all other haplotypes were pooled into a single 
group (in white). Also, haplotypes NAT2*14A and NAT2*14B were pooled into the NAT2*14 cluster. (B) Median-joining net-
works of the inferred NAT2 haplotypes within three geographical regions: sub-Saharan Africa, Europe, and 
East Asia. Only haplotypes with frequencies > 0.005 within a geographic area were considered to construct the networks. 
Circle areas are proportional to the haplotypes' frequency, and branch lengths are proportional to the number of mutations 
separating haplotypes. Haplotypes' labels are shown in black; mutations are shown in red on corresponding network branches.
A  B BMC Genetics 2008, 9:21 http://www.biomedcentral.com/1471-2156/9/21
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eral other African populations by Patin et al. [10] (Yoruba
from Nigeria, Akele Bantus from Gabon, Mbuti Pygmies
from the Democratic Republic of Congo, Chagga Bantu-
speakers from Tanzania, Somali and !Kung San from
Namibia). However, that same survey also detected novel
variants occurring at non negligible frequencies in several
Pygmy populations: up to one fourth of the individuals
presented an unknown acetylator status due to the high
prevalence of novel mutations with an unknown func-
tional effect. Therefore, further sequencing studies that
provide information about the entire frequency spectrum
rather than pre-selected variants are required to provide
an unbiased description of NAT2 sequence variation in
not yet investigated human populations.
Genetic structure of human populations at NAT2
The genetic diversity patterns observed at NAT2 are largely
consistent with those reported in many other studies of
different gene regions in the human genome. The inferred
levels of sequence diversity (Table 2) were found to be
consistent with values reported at other highly variable
human autosomal loci, such as LPL [18], GYPA [19], and
CCR5 [20]. The average sequence divergence between
human and chimpanzee (1.6%) was close to previous
Multidimensional scaling plot of Reynolds genetic distances among the 41 population samples of the worldwide genotyping sur- vey Figure 3
Multidimensional scaling plot of Reynolds genetic distances among the 41 population samples of the worldwide 
genotyping survey. The stress value is 0.07, indicating a very good fit of the projection to the original data. Samples are num-
bered according to their population code [see Additional file 1 and Additional file 2]. The shaded areas highlight the distribu-
tion of samples from sub-Saharan Africa, Europe, and East Asia in the plot.
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estimates of putatively neutral genomic regions [21], and
the estimated Ne  and  TMRCA were also found to be in
agreement with those of several other nuclear loci, which
estimate the human Ne and TMRCA to be close to 10,000
and ~1 My, respectively [22,23]. However, one should be
aware that the stochastic nature of the coalescence process
used to describe the genealogy, the assumptions that have
to be made (for example, the absence of recombination
and selection) and the removal of data (rare recombinant
haplotypes) can all have important effects on inference
and lead to imprecise estimations. Sub-Saharan Africans
displayed the greatest haplotype diversity at NAT2 and
also had the largest number of unique haplotypes [see
Table 3]. Furthermore, haplotypes described outside
Africa were essentially a subset of the collection of NAT2
haplotypes found within Africa. These features of molecu-
lar diversity are generally interpreted as strong evidence
for the 'Out-of-Africa' model which hypothesizes that all
modern populations emerged from a common ancestral
population in Africa [22]. A linear diversity gradient away
from Africa was indeed observed at NAT2 in this study,
with African populations showing the highest heterozy-
gosities, then successively decreasing in Europeans and
East Asians [see Additional file 1]. This pattern is sugges-
tive of a gradual loss of diversity in successive coloniza-
tion bottlenecks as our species grew and spread all over
the world [24]. Ngawbe and Embera Amerindians dis-
played comparable levels of haplotype diversity to East
Asians (0.42 and 0.57, respectively). However, this last
observation contrasts with the recent findings of Fuselli et
al. [25] that demonstrated higher NAT2 intra-population
genetic diversity in Native Americans than in East Asians,
implying more complex processes in the evolution of
populations at NAT2  than the simple linear model
exposed here above.
Another line of evidence supporting a relatively recent
African origin of modern humans came from our analysis
of LD patterns at NAT2: the lowest levels of LD were found
in African populations, a common finding in empirical
studies of LD in human populations. This is consistent
with a larger long-term effective size of African popula-
tions and/or a bottlenecked population history of non-
African populations [22,26]. Even within a small gene like
NAT2, the SNP markers appeared to be poorly correlated
in sub-Saharan Africans.
We observed a particular pattern of genetic diversity at
NAT2 for the Thai sample compared to the other East
Asian populations examined. Notably, the frequency of
NAT2*4 was found to be significantly lower in Thai (0.30
versus around 0.50 in other Asian populations), resulting
in a larger fraction of slow acetylators in this sample (50%
versus 5–20%). Interestingly, among the East Asian popu-
lations investigated, the Thai sample is the only represent-
ative of the variation of NAT2  in Southern East Asia.
Because the full NAT2  gene diversity has not yet been
investigated in other Southeast Asian populations, it is
not possible to conclude whether this population harbors
a specific profile with respect to this genetic system, or if it
resembles other Southeast Asians. Further data from these
latter populations are needed to speculate on a possible
genetic differentiation pattern between Northern and
Southern East Asian populations at the NAT2 locus.
Possible selective pressures acting on NAT2
Because of its role in the detoxification of exogenous sub-
stances, the NAT2  gene has long been considered as a
likely target of population-specific selective pressures. But
many questions remain about the roles that population
history and natural selection have played in shaping the
diversity of NAT2. An intriguing point about this gene
concerns the high frequency of poor-metabolizers and
slow acetylator alleles in most human populations. This
might represent the evolution of balanced polymor-
phisms, maintained by natural selection through hetero-
zygote advantage or spatial-temporal selection of
alternative alleles, as it has been shown for G6PD defi-
ciencies or phenylketonuria [27,28]. An alternative expla-
nation is that NAT2 may evolve under no evolutionary
constraint, this enzyme being not essential from an evolu-
tionary perspective, maybe because it is dispensable or
redundant with other enzymes. In terms of the detoxifica-
tion of potentially harmful environmental aromatic
Table 4: FST values inferred from the 41 samples of the worldwide genotyping survey for each of the seven common SNPs of the NAT2 
gene.
G191A C282T T341C C481T G590A A803G G857A Average FST over all loci
World subdivided into
Five geographic groups (41 populations)a 0.104 0.004c 0.257 0.231 0.022 0.241 0.061 0.152
Three geographic groups (35 populations)b 0.122 -0.001c 0.308 0.280 0.011 0.291 0.074 0.189
a Sub-Saharan Africa, Europe/North Africa, Central/South Asia, East Asia, Central America [see Additional file 1 for the population composition of 
each geographic area]
b Sub-Saharan Africa, Europe/North Africa, East Asia
c Not significantly different from 0 at the 5% levelBMC Genetics 2008, 9:21 http://www.biomedcentral.com/1471-2156/9/21
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amines, NAT1 seems indeed to be more active than NAT2,
which preempts the latter's role as a key adaptation to
increase the fitness of our species [16].
In this study, we investigated whether the patterns of
sequence variation at NAT2 were consistent with a stand-
ard, neutral equilibrium model in 13 populations of sub-
Saharan Africa. All neutrality tests found no evidence of a
departure from selective neutrality. But making robust
inferences on the action of natural selection at a particular
locus requires a thorough characterization of population
history, since the neutral null hypothesis is a composite
hypothesis that also makes assumptions regarding the
demography of the populations. It is typically assumed
that the population is in equilibrium at constant size and
with no population subdivision. But suppose that African
populations did pass through a relatively narrow bottle-
neck in the late Pleistocene and then expand. In this case,
the observed data might reflect the antagonistic effects of
a bottleneck (which increases the frequency of rare alleles)
and balancing selection (which decreases that frequency),
and the apparent evidence in favour of a neutral model of
evolution would be an artefact, produced by the con-
founded effects of these two opposing forces. However,
the results of several studies have suggested that sub-Saha-
ran African sequence diversity was compatible with an
equilibrium model of long-term constant population size
and random mating [29-32]. They showed that rapid
growth from a small initial size was not compatible with
the African sequence data and that, if a prehistoric growth
occurred, it started from a relatively large Palaeolithic
population. Therefore, under such an equilibrium model,
NAT2 can be considered as a neutrally evolving gene, at
least in the sub-Saharan African populations investigated.
Further studies are needed to determine whether this find-
ing can be generalized to all African populations. It would
be also useful to increase both the number of individuals
studied and the size of the genomic region surveyed (by
investigating for instance the entire NAT2 gene sequence
which spans around 10 kb) to increase the power of neu-
trality tests which remains weak when the sample sizes
and the numbers of segregating sites are small.
The global level of genetic structure (FST = 0.123, P < 10-5)
was found to be remarkably consistent with the average
FST value for the human genome [33,34], and the high
correlation found between genetic and geographic dis-
tances (r = 0.47, P < 10-5) implies that patterns of human
diversity at NAT2 can largely be accounted for by the sim-
ple interaction of drift and geographically-structured gene
flow. However, while the overall degree of population
structure at NAT2 was similar to previously reported val-
ues for neutral markers [35,36], unusual patterns of differ-
entiation were observed between geographic groups. In
particular, a striking differentiation of East Asia both from
Europe and from Africa was found, a result that could sug-
gest the action of region- or of population-specific selec-
tive pressures. A large variance in FST values was observed
for individual SNPs (Table 4), with the highest FST values
being observed between European and East Asian popula-
tions for the three SNPs T341C, C481T, and A803G
(around 40%). These values were compared to the empir-
ical distribution of FST across a 400-kb region encompass-
ing the NAT gene family (composed of the two functional
NAT1 and NAT2 genes, and the NATP pseudogene) [see
Additional file 3]. FST were computed for 550 individual
markers spanning the 400-kb NATs region by using pub-
licly available HapMap SNP data (the International Hap-
Map Project [37] /Public Release #20). They all measured
population differentiation between 60 Europeans and 90
East Asians. The FST  values displayed by the T341C,
C481T, and A803G SNP variants (pointed by a black
arrow in the Additional file 3) of the NAT2 coding region
appeared to be exceptionally large since they differed by
more than three standard deviations from the mean value
computed for all 550 markers in the 400-kb region (solid
horizontal line in Additional file 3). Although this crite-
rion does not have any specific statistical significance, we
may expect that such exceptional values are beyond those
that might be accounted for by variation at neutral loci.
High FST values were also observed in the 25-kb region fol-
lowing the NAT2  gene. This may be explained by the
strong LD linking sites within the NAT2 coding exon and
sites in the noncoding region next to the NAT2  gene,
observed in both European [see Additional file 4] and East
Asian populations [see Additional file 5]. Indeed, if posi-
tive natural selection was acting on NAT2, such as through
local adaptation, it would induce hitchhiking of nearby
regions [38] and would increase interpopulation differen-
tiation at linked neutral sites, as distinct haplotypes would
be fixed in different populations. Besides, it is also inter-
esting to note the high FST values in the region surround-
ing the NAT1  gene and, surprisingly, in a noncoding
segment preceding the NATP pseudogene.
By contrasting the FST of individual SNPs to the empirical
distribution of FST across a genomic region, it is possible
to identify those loci that exhibit unusual patterns of pop-
ulation differentiation as potential candidates for the
action of natural selection [39,40]. Several studies have
used this strategy to detect the action of selection on spe-
cific genes or on a genome-wide scale [33,34,41]. How-
ever, genome-wide surveys of FST have demonstrated
substantial variation of FST values across the genome,
even among SNPs that are very close to each other [33,34],
thus stressing the difficulty to distinguish between non-
random events such as local selection and random events
such as extreme genetic drift as the agents responsible for
the unusual patterns observed. Individual-marker FST
estimates are probably too variable to be reliable indica-BMC Genetics 2008, 9:21 http://www.biomedcentral.com/1471-2156/9/21
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tors of past selective events and other more powerful tests
are required to provide unambiguous evidence of natural
selection. The availability of genotype data for additional
markers surrounding the NAT2 gene would enable the
implementation of the long-range haplotype test [42]
which has better power for identifying signatures of recent
positive selection.
A possible explanation for the unusually large difference
in allele frequencies observed between European and East
Asian populations for the NAT2  variants could be the
impact of population-specific selective pressures. The
main molecular basis for the high discrepancy between
Europeans and East Asians is that the most common allele
at the NAT2 locus in Europeans (NAT2*5B) is very rare in
East Asians and could represent a different selective
advantage within the gene pools of these separate popula-
tions. Patin et al. [43] found evidence of a rapid increase
in frequency of the NAT2*5B haplotype in Western and
Central Eurasian populations in the last ~6,500 years in
response to positive selection, suggesting that this slow
allele probably conferred some selective advantage to its
carriers in this part of the world. A thorough survey of
NAT2 sequence variation in East Asians will be necessary
to determine whether the predominance of the rapid-
acetylator NAT2*4 allele over the slow ones is the result of
local positive selection or whether it can be explained by
stochastic processes such as genetic drift.
Conclusion
This study provides a thorough description of the world-
wide haplotype diversity and LD structure of the NAT2
gene. We found that patterns of NAT2 sequence variation
are consistent with selective neutrality in all sub-Saharan
African populations investigated, whereas the high level
of population differentiation between Europeans and East
Asians inferred from SNPs may suggest population-spe-
cific selective pressures acting at this locus, probably
caused by differences in diet or exposure to other environ-
mental signals.
Methods
NAT2 sequencing of the Mandenka
Full sequence diversity of NAT2 exon 2, which contains
the entire protein-coding region, was determined in 97
healthy unrelated individuals (62 men, 35 women) from
the Niokholo Mandenka. This agriculturalist population
from Eastern Senegal speaks a language belonging to
Mande, a major primary branch of the Niger-Congo lan-
guage family. We used DNA extracted from the lymphob-
lastoid cell lines (LCL) described in Excoffier et al. [44].
The sample size considered was sufficient to detect NAT2
variants present at a frequency ≥ 3%, with a probability of
at least 99%.
A 1,211-bp fragment covering the entire coding region of
NAT2 was amplified by PCR and subsequently sequenced
on both DNA strands on an ABI 3730xl automated
sequencer (Applied Biosystems) using three internal
primer pairs, as described in Cascorbi et al. [45] (sequenc-
ing service provided by Macrogen, Seoul, Korea). The
sequence variation of a 1188-bp fragment (from nt -59 to
nt +1129) was fully surveyed, which includes the 870 bp
of the NAT2 coding exon and 318 bp of non-coding flank-
ing parts. All singletons were verified by PCR reamplifica-
tion and resequencing the PCR products in both
directions. The observed genotype frequencies at all poly-
morphic sites were in conformity with the assumptions of
Hardy-Weinberg equilibrium when tested using Fisher's
exact tests. Haplotype reconstruction was performed using
the Bayesian method implemented in PHASE v.2.1 [46].
All 194 haplotype sequences were submitted to GenBank
[GenBank:DQ904040-DQ904233].
For comparison purposes, we merged the NAT2 sequence
data set with a collection of previously published
sequences of the NAT2 coding exon (870 bp) [10]. This
additional dataset consists in 285 individuals from 12
sub-Saharan African populations, including Yoruba from
Nigeria (N = 31); Baka Pygmies (N = 31), Bakola Pygmies
(N = 26), Bedzan Pygmies (N = 32) and Ngumba Bantus
(N = 16) from Cameroon; Baka Pygmies (N = 16) and
Akele Bantus (N = 26) from Gabon; Biaka Pygmies from
Central African Republic (N = 24); Mbuti Pygmies from
the Democratic Republic of Congo (N = 24); Chagga
Bantu-speakers from Tanzania (N = 32); Somali (N = 20)
and !Kung San from Namibia (N = 7).
NAT2 worldwide genotyping survey
We selected from published reports up to 2006 all the
population samples that were genotyped for the seven
most common SNPs at NAT2 and for which genotype data
was available. Among these seven SNPs, all located in the
coding exon, four result in an amino acid substitution that
leads to a significant decrease in acetylation capacity
(G191A, T341C, G590A, G857A). The other three are
either silent mutations (C282T, C481T) or a non-synony-
mous substitution that does not alter the phenotype
(A803G).
A complete list of the selected samples is provided in
Additional file 1, along with a full description of each
sample and references. The collected data consisted of
6,727 individuals (13,454 chromosomes) from 41
human populations representing major geographic
regions: Europe (17 samples), North Africa (1), sub-Saha-
ran Africa (8), Central/South Asia (3), East Asia (9), and
Central America (3). The geographical distribution of the
samples is shown in Additional file 2. Sample sizes range
from 24 (Somali) to 1000 (Korean) individuals, with anBMC Genetics 2008, 9:21 http://www.biomedcentral.com/1471-2156/9/21
Page 12 of 14
(page number not for citation purposes)
average of 160 individuals per sample. For 13 samples,
genotype data at one SNP (11 samples) or two SNPs (2
samples) out of the seven were missing. It involves either
G191A (which has been shown to be extremely rare in
Europeans and Asians) or the synonymous C282T poly-
morphism. These samples were excluded from LD analy-
ses.
Statistical analyses
All sequence analyses were performed on both the Man-
denka sample and on each of the 12 African samples of
Patin et al. [10]. Homologous sequences from one chim-
panzee (Pan troglodytes; Ensembl Chinpanzee genome)
and one rhesus monkey (Macaca mulatta; GenBank
XM_001098734) were used to infer SNPs' ancestral state.
Each of these also served as an outgroup for evolutionary
and population genetic tests.
DnaSP v.4.10 [47] was used to compute, in each sample,
the nucleotide (π) and haplotype (H) diversity, Watter-
son's θw [48], as well as to perform several neutrality tests
to detect signals of natural selection: Tajima's D [49], Fu
and Li's F* and D* [50], Fu's Fs [51], and Fay and Wu's H
[52]. The statistical significance of the tests was estimated
from 10,000 coalescent simulations of an infinite site
locus, conditional on sample size, both with and without
recombination. The McDonald-Kreitman test [53] was
applied to detect deviation from the neutral expectation
of equal rates of nonsynonymous to synonymous poly-
morphism within humans and nonsynonymous to syn-
onymous fixed substitutions between humans and
chimpanzee.
A coalescence model for the ancestral history of a sample
of genes was used to estimate the time scale of polymor-
phic variation in the NAT2 gene. The time to the most
recent common ancestor (TMRCA) and mutation ages were
estimated from the NAT2 gene tree, conditional on a max-
imum-likelihood estimate of θ( ), the population
mutation parameter. These estimates were computed with
GeneTree v.9.0 [54] (running 106 replications), under a
standard coalescence model assuming neutrality, the infi-
nite-sites mutation model (haplotypes presumably
affected by recurrent mutation or recombination were
removed from the analysis), random mating, and con-
stant population size. All estimates were inferred on indi-
vidual population samples, to avoid biases due to
population structure. Time, scaled in 2Ne units, was con-
verted into years by use of a 25-year generation time and
the value of the effective population size (Ne) obtained as
 divided by 4 μ. The neutral mutation rate per gene
per generation (μ) was estimated based on human-chim-
panzee sequence divergence, assuming a divergence time
of 5 million years (My) [55].
For the worldwide genotyping survey, we inferred NAT2
haplotypes from the unphased multi-locus genotypes
using PHASE v.2.1 software [46]. The individual acetyla-
tion phenotypes were then predicted from the haplotype
combination at NAT2, in accordance with the acknowl-
edged classification of NAT2* alleles based on their func-
tional impact [see Table 3]: individuals with two low
activity alleles were classified as slow acetylators, those
with two functional alleles as rapid acetylators, and those
with both a slow and a functional allele as intermediate
acetylators.
Median-joining networks [56] describing the mutational
relationships among the inferred NAT2 haplotypes were
generated using Network 4.1.1 software [57].
Population structure in the worldwide genotyping survey
set was investigated by an analysis of molecular variance
(AMOVA) [58] that included the molecular distance
matrix among NAT2 haplotypes. Population differentia-
tion was tested by permutation tests (20,000 permuta-
tions) based on the FST statistic. Coancestry coefficients, or
linearized FST values [59], were computed among popula-
tions and the resulting genetic distance matrix was used
for multidimensional scaling analysis (MDS) [60] per-
formed with the NTSYS v.2.1 software [61]. A Mantel test
was applied to test the correlation of pairwise genetic dis-
tances with geographic distances, computed as great-circle
distances between populations from their coordinates of
latitude and longitude (US Caucasians and Ashkenazi
Jews were excluded from the analysis since they could not
be allocated precisely to a specific area). All calculations,
including random-permutation procedures to assess sta-
tistical significance, were performed by use of the Arle-
quin v.3.0 package [62].
Pairwise LD between the seven genotyped SNPs was esti-
mated by computing the r2 statistic [63] with DnaSP [47],
after the exclusion, in each population of the worldwide
genotyping survey, of SNPs with minor allele frequency
(MAF) < 0.05. Statistical significance of LD between SNP
pairs was assessed using Fisher's exact tests followed by
Bonferroni corrections. Mantel tests to compare r2 matri-
ces were performed using the program CADM [64]. Com-
parisons were made between populations within each
continental group. Subsequently, r2 values were recalcu-
lated for populations pooled into geographical groups
and Mantel tests were applied.
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